#esmo19 OR #esmo2019, Twitter, 10/2/2019 3:10:18 AM, 211591


FAQ | Problem?

#esmo19 OR #esmo2019 Twitter NodeXL SNA Map and Report for Tuesday, 01 October 2019 at 21:57 UTC
#esmo19 OR #esmo2019 Twitter NodeXL SNA Map and Report for Tuesday, 01 October 2019 at 21:57 UTC
From:
scotpublichealth
Uploaded on:
October 02, 2019
Short Description:
#esmo19 OR #esmo2019 via NodeXL http://bit.ly/2p4bB7l
@myesmo
@katsuakimaehara
@nejm
@scienceatbms
@oncoalert
@_timos_
@lqventures
@andybiotech
@fabioschutz78
@breastdocuk

Top hashtags:
#esmo19
#esmo2019
#oncoalert
#immunotherapy
#cancer
#lcsm
#oncology
#bcsm
#eons12

Description:
Description


This graph collects tweets from two previous graphs to cover a combined period from Sunday, 22 September 2019 at 10:23 UTC to Tuesday, 01 October 2019 at 21:56 UTC.

https://nodexlgraphgallery.org/Pages/Graph.aspx?graphID=211554
5-day, 13-hour, 34-minute period from Sunday, 22 September 2019 at 10:23 UTC to Friday, 27 September 2019 at 23:58 UTC.

https://nodexlgraphgallery.org/Pages/Graph.aspx?graphID=211338
2-day, 2-hour, 22-minute period from Friday, 27 September 2019 at 16:04 UTC to Sunday, 29 September 2019 at 18:26 UTC

https://nodexlgraphgallery.org/Pages/Graph.aspx?graphID=211591
2-day, 13-hour, 48-minute period from Sunday, 29 September 2019 at 08:08 UTC to Tuesday, 01 October 2019 at 21:56 UTC.

The graph represents a network of 9,187 Twitter users whose recent tweets contained "#esmo19 OR #esmo2019", or who were replied to or mentioned in those tweets, taken from individual data sets limited to a maximum of 18,000 tweets. The final graph was obtained from Twitter on Tuesday, 01 October 2019 at 22:32 UTC.

Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.

There is an edge for each "replies-to" relationship in a tweet, an edge for each "mentions" relationship in a tweet, and a self-loop edge for each tweet that is not a "replies-to" or "mentions".

The graph is directed.

The graph's vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.

The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.


Author Description


Overall Graph Metrics
Vertices : 9187
Unique Edges : 25432
Edges With Duplicates : 65233
Total Edges : 90665
Self-Loops : 6435
Reciprocated Vertex Pair Ratio : 0.0533060632734428
Reciprocated Edge Ratio : 0.10121666461841
Connected Components : 301
Single-Vertex Connected Components : 205
Maximum Vertices in a Connected Component : 8712
Maximum Edges in a Connected Component : 89798
Maximum Geodesic Distance (Diameter) : 10
Average Geodesic Distance : 3.618885
Graph Density : 0.000482096704629368
Modularity : 0.269072
NodeXL Version : 1.0.1.419

Top Influencers: Top 10 Vertices, Ranked by Betweenness Centrality
Top URLs
Top URLs in Tweet in Entire Graph:
[65] https://www.esmo.org/Conferences/ESMO-Congress-2019/Social-Media?hit=some
[63] https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30620-5/fulltext
[36] https://www.medscape.org/symposium/thrombosis-registration
[29] https://www.statnews.com/2019/09/28/amgens-kras-blocking-drug-shows-minimal-effect-in-colon-cancer-patients/
[28] https://www.esmo.org/Oncology-News/Nivolumab-Challenges-Sorafenib-as-First-line-Treatment-in-Advanced-HCC?hit=some
[25] https://twitter.com/NEJM/status/1177956124990902273
[24] https://www.nature.com/articles/s41572-019-0111-2?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NRRJ_2_SJB_nrdp_editorial_tweet
[20] https://www.esmo.org/Conferences/ESMO-Congress-2019/Congress-Coverage/Meeting-Resources?hit=some
[18] https://twitter.com/anacasbal/status/1178205229445255169
[18] https://www.nejm.org/doi/full/10.1056/NEJMoa1910231?query=featured_home&cookieSet=1

Top URLs in Tweet in G1:
[41] https://www.esmo.org/Conferences/ESMO-Congress-2019/Social-Media?hit=some
[20] https://www.esmo.org/Oncology-News/Nivolumab-Challenges-Sorafenib-as-First-line-Treatment-in-Advanced-HCC?hit=some
[14] https://www.esmo.org/Conferences/ESMO-Congress-2019/Congress-Coverage/Meeting-Resources?hit=some
[13] https://twitter.com/matteolambe/status/1177465884467585030
[12] https://twitter.com/vpavinato/status/1177819166327349248
[12] https://academic.oup.com/annonc/article/29/8/1869/4975732
[11] https://twitter.com/NEJM/status/1177956124990902273
[11] https://twitter.com/APassaroMD/status/1174744929400233984
[10] http://dailyreporter.esmo.org/not-just-for-girls-so-who-else-should-be-vaccinated-for-hpv/?hit=some
[10] http://dailyreporter.esmo.org/living-anticancer-medicines-has-a-new-era-started/?hit=some

Top URLs in Tweet in G2:
[54] https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30620-5/fulltext
[18] https://oncologiabrasil.com.br/esmo-19
[12] https://www.ctu.mrc.ac.uk/news/news-stories/2019/september/more-men-with-prostate-cancer-can-be-spared-radiotherapy-after-surgery/
[11] https://twitter.com/NEJM/status/1177956124990902273
[11] https://info.thelancet.com/conference-alerts?utm_campaign=lancet-conf-alerts&utm_source=twitter&utm_medium=social
[10] https://www.esmo.org/Conferences/ESMO-Congress-2019/Social-Media?hit=some
[9] https://www.thelancet.com/for-authors?utm_campaign=exhibits19&utm_source=twitter&utm_medium=social
[8] https://www.onclive.com/conference-coverage/esmo-2019/cabazitaxel-emerges-as-third-line-standard-for-metastatic-crpc
[7] https://twitter.com/neerajaiims/status/1178270063465512960
[7] https://iob-onco.com/dr-ana-oaknin/

Top URLs in Tweet in G3:
[15] http://bit.ly/2mLKFrZ?utm_source=dlvr.it&utm_medium=twitter
[15] https://medical-tribune.co.jp/special/other/1909_onc/?utm_source=twitter&utm_medium=link&utm_campaign=190924
[11] http://www.vjoncology.com/
[9] https://www.esmo.org/Conferences/ESMO-Congress-2019/Social-Media?hit=some
[9] https://www.elmundo.es/ciencia-y-salud/salud/2019/09/28/5d8c9b72fdddffba188b460f.html
[9] https://diagnostics.roche.com/global/en/events/esmo-2019.html?utm_campaign=esmo2019&utm_source=twitter&utm_medium=post&utm_term=&utm_content=rd:global:en:rms:lnk-events-geninfo
[8] https://twitter.com/MyelomaEurope/status/1177984470319861761
[8] https://twitter.com/LMC_PACIENTES/status/1178344292781301760/photo/1
[7] https://www.mpeurope.org/2019/09/28/esmo-2019-photo-gallery/
[7] https://www.medscape.com/viewarticle/918846?src=soc_tw_190927_mscpedt_news_mdscp_esmopreview&faf=1

Top URLs in Tweet in G4:
[5] https://wwwext.amgen.com/media/news-releases/2019/09/amgen-announces-new-clinical-data-evaluating-novel-investigational-krasg12c-inhibitor-in-patients-with-solid-tumors-at-esmo-2019/
[5] https://www.esmo.org/Press-Office/Press-Releases/ESMO-Congress-breast-cancer-Monaleesa3-monarch2-Sledge-Slamon
[4] https://www.mdanderson.org/publications/annual-report/annual-report-2017/unraveling-a-complex-disease-with-blood-draw.html?cmpid=twitter_annualreport_science
[4] https://www.sitcancer.org/research/cancer-immunotherapy-guidelines
[3] https://www.mdanderson.org/newsroom/parp-inhibitor-plus-chemotherapy-improves-progression-free-survival-for-advanced-ovarian-cancer-patients.h00-159306201.html?cmpid=twitter_newsroom_ovarian_clinicaltrials
[3] https://www.mdanderson.org/newsroom/triplet-targeted-therapy-improves-survival-for-patients-with-advanced-colorectal-cancer-and-BRAF-mutations.h00-159304623.html?cmpid=twitter_newsroom_colorectal_science
[3] http://r.socialstudio.radian6.com/287d9ffa-2ca5-4c89-8ab2-9d62724e8da9
[3] https://twitter.com/odpmdpdscreen/status/1178571454197223424
[3] https://www.healio.com/hematology-oncology/genitourinary-cancer/news/online/{37fcbc39-f0ec-4300-a77d-d8d91f965783}/atezolizumab-extends-pfs-in-metastatic-urothelial-cancer
[3] https://www.healio.com/hematology-oncology/prostate-cancer/news/online/{54ba29bf-378e-4090-8551-738a3dd9bece}/cabazitaxel-improves-outcomes-among-certain-men-with-metastatic-prostate-cancer

Top URLs in Tweet in G5:
[23] https://www.statnews.com/2019/09/28/amgens-kras-blocking-drug-shows-minimal-effect-in-colon-cancer-patients/
[19] https://www.nature.com/articles/s41572-019-0111-2?utm_source=twitter&utm_medium=social&utm_content=organic&utm_campaign=NRRJ_2_SJB_nrdp_editorial_tweet
[12] https://www.evaluate.com/vantage/articles/events/conferences/vantage-esmo-2019-roundup
[12] https://www.statnews.com/2019/09/28/astrazeneca-and-gsk-drugs-reduce-risk-of-ovarian-cancer-returning/
[10] https://www.evaluate.com/vantage/articles/events/conferences/esmo-2019-preview-parps-parade
[9] https://www.evaluate.com/vantage/articles/events/conferences/esmo-2019-lynparza-pushes-parps-forward-again
[9] https://www.evaluate.com/vantage/articles/events/conferences/esmo-2019-kras-springs-leak
[8] https://www.evaluate.com/vantage/articles/events/conferences/esmo-2019-glaxos-parp-ambitions-get-boost
[8] https://www.loxooncology.com/docs/presentations/LOXO-292_ESMO2019_28EPT2019.pdf
[8] https://www.deciphera.com/wp-content/uploads/2019/09/INVICTUS-Oral-Presentation-Slide-Deck_2019Sept30-FINAL-v3.pdf

Top URLs in Tweet in G6:
[36] https://www.medscape.org/symposium/thrombosis-registration
[4] https://www.medscape.com/viewarticle/918999?src=soc_tw_191004_mscpedt_news_onc_bcsm&faf=1
[4] https://www.medscape.com/viewarticle/918846?src=soc_tw_190925_mscpedt_news_mdscp_esmopreview&faf=1
[4] https://www.medscape.com/viewarticle/919156
[4] https://soundcloud.com/bmjpodcasts/reimbursement-reality-for-off-label-use-olu-of-drug-treatments-in-cancer-care
[4] https://www.esmo.org/Press-Office/Press-Releases/ESMO-Congress-anticancer-drugs-cost-Marino-Vokinger?hit=some
[4] https://www.medscape.com/viewarticle/918846?src=soc_tw_190927_mscpedt_news_mdscp_esmopreview&faf=1
[4] https://www.medscape.com/viewarticle/918846?src=soc_tw_190928_mscpedt_news_mdscp_esmopreview&faf=1
[3] http://bit.ly/MedscapeLIVE_THROMBOSIS19
[2] https://www.medscape.com/viewarticle/919001?src=soc_tw_191004_mscpedt_news_onc_commentaryesmo&faf=1

Top URLs in Tweet in G7:
[1] http://www.bms.com/media/media-library/scientific-media-resources/oncology-timeline.html?cid=s_903290
[1] https://news.bms.com/press-release/corporatefinancial-news/adjuvant-treatment-opdivo-nivolumab-continues-demonstrate-exte?linkId=74418748
[1] https://news.bms.com/press-release/corporatefinancial-news/five-year-outcomes-opdivo-nivolumab-combination-yervoy-ipilimu?linkId=74418681

Top URLs in Tweet in G8:
[4] https://www.saluteh24.com/il_weblog_di_antonio/2019/09/mesotelioma-pleurico-i-dati-di-pharmamar-al-congresso-europeo-di-barcellona-esmo19.html
[3] https://efpia.eu/about-medicines/use-of-medicines/disease-specific-groups/fighting-cancer/
[3] http://www.bayer.com/en/media.aspx
[2] https://efpia.eu/we-wont-rest/connecting-healthcare/connecting-healthcare-projects/
[2] https://twitter.com/AndresC27622123/status/1177522782705504256
[2] https://www.pharmastar.it/news/oncoemato/spesa-per-i-farmaci-oncologici-in-crescita-servono-reti-e-prevenzione-ad-hoc-esmo2019-30388
[2] https://twitter.com/myESMO/status/1176077309360652290
[2] https://twitter.com/efpia/status/1177510773087563776
[1] https://www.esmo.org/Conferences/ESMO-Congress-2019/Programme
[1] https://twitter.com/MSDInvents/status/1179018125662142465

Top URLs in Tweet in G9:
[4] https://www.dovepress.com/index.php
[3] https://www.linkedin.com/slink?code=fAcvTvm
[2] https://www.efesalud.com/esmo-cancer-ovario-2019
[2] https://www.efesalud.com/esmo-2019-medir-beneficios-reales-medicamento-oncologico/
[2] http://www.msd.com/about/featured-stories/you-never-forget-that-day.html
[2] https://www.denunciascolectivas.org/2019/09/IRPH-ultima-hora-DenunciasColectivas.html
[2] https://news.bms.com/press-release/corporatefinancial-news/five-year-outcomes-opdivo-nivolumab-combination-yervoy-ipilimu
[2] https://www.positivos.com/user/aironshirt/
[2] https://www.latostadora.com/aironshirt1/
[2] https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/esmo-2019/?utm_source=twitter&utm_medium=social&utm_campaign=ona_daily-social-post

Top URLs in Tweet in G10:
[1] https://soundcloud.com/bmjpodcasts/esmo-presidential-symposium-phase-iii-paola-1-olaparib-in-newly-diagnosed-advanced-ovarian-cancer
[1] https://www.esmo.org/content/download/211169/3738827/file/EN-Cancer-Pain-Management-Guide-for-Patients.pdf
[1] https://www.esmo.org/Conferences/ESMO-Congress-2019/Congress-Coverage/Meeting-Resources?hit=some
[1] https://jamanetwork.com/journals/jama/pages/esmo?utm_source=twitter&utm_medium=social_jamanetwork&utm_term=2678248935&utm_content=followers-article_engagement-tfl-&utm_campaign=brand_marketing&linkId=74274741
[1] https://jamanetwork.com/journals/jama/pages/esmo
[1] https://twitter.com/JAMANetwork/status/1177538376720879617
[1] https://jamanetwork.com/journals/jama/pages/esmo?utm_source=twitter&utm_medium=social_jamanetwork&utm_term=2678248984&utm_content=followers-article_engagement-tfl-&utm_campaign=brand_marketing&linkId=74274752
[1] https://jamanetwork.com/journals/jama/pages/esmo?utm_source=twitter&utm_medium=social_jamanetwork&utm_term=2678248965&utm_content=followers-article_engagement-tfl-&utm_campaign=brand_marketing&linkId=74274746
[1] https://jamanetwork.com/journals/jama/pages/esmo?utm_source=twitter&utm_medium=social_jamanetwork&utm_term=2678248919&utm_content=followers-article_engagement-tfl-&utm_campaign=brand_marketing&linkId=74274738
[1] https://jamanetwork.com/journals/jama/pages/esmo?utm_source=twitter&utm_medium=social_jamanetwork&utm_term=2678248971&utm_content=followers-article_engagement-tfl-&utm_campaign=brand_marketing&linkId=74274750

Top Domains
Top Domains in Tweet in Entire Graph:
[1790] twitter.com
[503] esmo.org
[156] onclive.com
[129] medscape.com
[128] instagram.com
[97] linkedin.com
[95] evaluate.com
[91] thelancet.com
[79] nejm.org
[75] nature.com

Top Domains in Tweet in G1:
[800] twitter.com
[318] esmo.org
[38] targetedonc.com
[37] oncoinfo.it
[32] medscape.com
[28] nejm.org
[26] oup.com
[22] radian6.com
[21] nature.com
[20] onclive.com

Top Domains in Tweet in G2:
[304] twitter.com
[125] onclive.com
[80] thelancet.com
[46] esmo.org
[40] urotoday.com
[18] com.br
[16] medicinematters.com
[15] nejm.org
[15] saluteh24.com
[14] immedicohospitalario.es

Top Domains in Tweet in G3:
[422] twitter.com
[107] instagram.com
[51] bit.ly
[45] medscape.com
[44] esmo.org
[36] roche.com
[27] vjoncology.com
[25] co.jp
[16] ow.ly
[15] dlvr.it

Top Domains in Tweet in G4:
[54] twitter.com
[33] healio.com
[26] esmo.org
[18] mdanderson.org
[12] nejm.org
[12] youtube.com
[9] sitcancer.org
[9] gene.com
[9] obroncology.com
[8] amgen.com

Top Domains in Tweet in G5:
[73] evaluate.com
[68] 1stoncology.com
[53] twitter.com
[35] statnews.com
[34] nature.com
[17] fiercepharma.com
[16] innate-pharma.com
[14] nejm.org
[14] endpts.com
[11] pharmafile.com

Top Domains in Tweet in G6:
[36] medscape.org
[31] medscape.com
[26] twitter.com
[9] bit.ly
[7] esmo.org
[4] ac.uk
[4] soundcloud.com
[3] clinicaltrials.gov
[2] nejm.org
[2] benzinga.com

Top Domains in Tweet in G7:
[3] bms.com

Top Domains in Tweet in G8:
[18] twitter.com
[18] saluteh24.com
[12] efpia.eu
[12] linkedin.com
[6] fondazioneveronesi.it
[5] esmo.org
[5] radian6.com
[4] pharmaphorum.com
[4] bayer.com
[4] gsk.com

Top Domains in Tweet in G9:
[25] twitter.com
[24] linkedin.com
[15] saluteh24.com
[12] instagram.com
[11] crweworld.com
[11] cancertherapyadvisor.com
[9] esmo.org
[6] medinews.it
[5] medscape.com
[4] efesalud.com

Top Domains in Tweet in G10:
[13] jamanetwork.com
[4] twitter.com
[2] esmo.org
[1] soundcloud.com

Top Hashtags
Top Hashtags in Tweet in Entire Graph:
[20660] esmo19
[4534] esmo2019
[1843] oncoalert
[1514] immunotherapy
[1393] cancer
[1172] lcsm
[1107] oncology
[854] bcsm
[736] eons12
[569] melanoma



Top Hashtags in Tweet in G1:
[9087] esmo19
[1707] esmo2019
[1510] oncoalert
[1006] lcsm
[692] bcsm
[438] immunotherapy
[342] lungcancer
[297] cancer
[218] breastcancer
[207] nsclc

Top Hashtags in Tweet in G2:
[3295] esmo19
[643] esmo2019
[167] prostatecancer
[156] oncoalert
[129] bladdercancer
[119] pcsm
[96] barcelona
[89] rcc
[88] immunotherapy
[81] mocnaesmo

Top Hashtags in Tweet in G3:
[3567] esmo19
[956] esmo2019
[739] cancer
[654] oncology
[619] eons12
[580] immunotherapy
[451] strategy
[450] followthepatient
[450] lucidquest
[449] insights

Top Hashtags in Tweet in G4:
[987] esmo19
[249] esmo2019
[129] immunotherapy
[109] ovariancancer
[70] livercancer
[56] colorectalcancer
[45] oncology
[41] crcsm
[41] podcast
[33] endcancer

Top Hashtags in Tweet in G5:
[953] esmo19
[155] melanoma
[103] esmo2019
[42] biotech
[39] immunotherapy
[37] cancer
[35] breastcancer
[30] iph5401
[30] monalizumab
[29] carcinomas

Top Hashtags in Tweet in G6:
[319] esmo19
[181] esmo2019
[104] medscapelive
[45] melanoma
[41] cancer
[36] nsclc
[26] immunotherapy
[21] melsm
[21] eons12
[20] prostatecancer

Top Hashtags in Tweet in G7:
[270] esmo19
[185] immunotherapy
[42] esophagealcancer
[33] cancerresearch
[10] cancer
[8] melanoma
[4] oncology
[4] precisionmedicine
[4] lungcancer
[3] livercancer

Top Hashtags in Tweet in G8:
[453] esmo19
[48] esmo2019
[44] ovariancancer
[44] trkfusioncancer
[38] cancerdurein
[26] dyk
[23] cancer
[22] wewontrest
[17] cancerdusein
[16] improvingcancercare

Top Hashtags in Tweet in G9:
[207] esmo19
[159] esmo2019
[30] cancer
[28] esmo
[24] oncology
[22] barcelona
[6] spain
[6] cancerresearch
[6] melanoma
[6] salute

Top Hashtags in Tweet in G10:
[197] esmo19
[40] day3
[26] esmo2019
[17] lungcancer
[7] bopa
[7] ovariancancer
[7] immunotherapy
[5] cyp
[5] pcsm
[4] melanoma

Top Words
Top Words in Tweet in Entire Graph:
[43536] Words in Sentiment List#1: Positive
[21649] Words in Sentiment List#2: Negative
[21] Words in Sentiment List#3: Angry/Violent
[926147] Non-categorized Words
[991332] Total Words
[31659] #esmo19
[7187] cancer
[7056] #esmo2019
[6201] myesmo
[6178] gt

Top Words in Tweet in G1:
[12879] #esmo19
[3305] #oncoalert
[3053] myesmo
[2773] #esmo2019
[2425] patients
[2376] cancer
[2207] oncoalert
[2052] #lcsm
[1878] os
[1415] trial

Top Words in Tweet in G2:
[5600] #esmo19
[1301] myesmo
[1186] patients
[1145] cancer
[1140] #esmo2019
[1129] trial
[877] results
[739] dr
[711] adjuvant
[625] data

Top Words in Tweet in G3:
[6016] #esmo19
[5312] gt
[2101] #cancer
[1974] #oncology
[1854] #immunotherapy
[1770] published
[1763] insights
[1750] esmo19
[1691] #strategy
[1685] #followthepatient

Top Words in Tweet in G4:
[1860] #esmo19
[748] cancer
[589] patients
[472] trial
[377] #esmo2019
[359] more
[346] nivolumab
[340] year
[325] survival
[313] advanced

Top Words in Tweet in G5:
[1518] #esmo19
[441] cancer
[369] patients
[333] data
[302] more
[296] 1
[278] yrs
[262] survive
[246] advanced
[228] combo

Top Words in Tweet in G6:
[544] #esmo19
[241] #esmo2019
[207] cancer
[181] patients
[125] #medscapelive
[113] advanced
[113] drugs
[111] nivolumab
[109] news
[107] combination

Top Words in Tweet in G7:
[336] #esmo19
[190] year
[185] #immunotherapy
[184] trace
[184] origin
[184] modern
[79] more
[68] follow
[48] diagnosed
[48] people

Top Words in Tweet in G8:
[626] #esmo19
[169] cancer
[118] di
[112] les
[103] patients
[88] oncology
[86] more
[79] women
[78] patient
[71] il

Top Words in Tweet in G9:
[212] #esmo19
[158] #esmo2019
[56] cancer
[45] barcelona
[36] patients
[35] esmo
[30] #cancer
[30] data
[28] more
[28] #esmo

Top Words in Tweet in G10:
[228] #esmo19
[86] myesmo
[82] cancer
[46] toxicity
[44] immunotherapy
[40] profiling
[40] #day3
[39] #esmo2019
[36] bopacommittee
[31] day

Top Word Pairs
Top Word Pairs in Tweet in Entire Graph:
[3605] gt,gt
[1764] esmo19,insights
[1764] insights,gt
[1764] gt,published
[1706] #esmo19,#followthepatient
[1706] #followthepatient,#lucidquest
[1115] #esmo19,#oncoalert
[1061] #esmo19,myesmo
[1050] myesmo,#esmo19
[788] pd,l1

Top Word Pairs in Tweet in G1:
[841] #esmo19,#oncoalert
[701] #esmo19,#lcsm
[551] pd,l1
[542] #esmo19,myesmo
[457] myesmo,#esmo19
[400] overall,survival
[381] breast,cancer
[363] #esmo19,oncoalert
[361] #oncoalert,#lcsm
[361] #esmo19,#bcsm

Top Word Pairs in Tweet in G2:
[345] prostate,cancer
[288] myesmo,#esmo19
[262] #esmo19,myesmo
[252] #esmo2019,#esmo19
[250] abi,enza
[194] 1st,line
[186] hr,0
[168] meta,analysis
[167] #esmo19,#oncoalert
[158] urotoday,#esmo2019

Top Word Pairs in Tweet in G3:
[3510] gt,gt
[1742] esmo19,insights
[1742] insights,gt
[1742] gt,published
[1684] #esmo19,#followthepatient
[1684] #followthepatient,#lucidquest
[539] #eons12,#esmo19
[414] published,instagram
[373] #immunotherapy,#cancer
[371] #cancer,#strategy

Top Word Pairs in Tweet in G4:
[255] 5,year
[229] trial,#esmo19
[173] kidney,cancer
[173] patients,metastatic
[153] learn,more
[142] nivolumab,alone
[142] see,checkmate
[135] checkmate,067
[135] follow,up
[130] year,survival

Top Word Pairs in Tweet in G5:
[150] patients,advanced
[149] advanced,#melanoma
[138] nivo,ipi
[137] ipi,combo
[132] cancer,#immunotherapy
[131] 10,yrs
[131] yrs,ago
[131] ago,1
[131] 1,20
[131] 20,patients

Top Word Pairs in Tweet in G6:
[78] thrombo,inflammation
[72] advanced,melanoma
[72] ipilimumab,nivolumab
[66] news,combination
[66] progression,advanced
[65] #esmo19,now
[65] now,live
[51] royalmarsdennhs,icr_london
[50] breaking,news
[47] five,years

Top Word Pairs in Tweet in G7:
[184] year,trace
[184] trace,origin
[184] origin,modern
[184] modern,#immunotherapy
[184] #immunotherapy,#esmo19
[40] research,exploring
[40] exploring,improve
[40] improve,outcomes
[40] outcomes,more
[40] more,570k

Top Word Pairs in Tweet in G8:
[68] les,personnes
[68] personnes,qui
[41] vrai,ou
[41] ou,faux
[39] #esmo19,#improvingcancercare
[38] find,out
[35] #esmo19,vrai
[35] plus,risque
[35] risque,développer
[34] faux,les

Top Word Pairs in Tweet in G9:
[14] #esmo,#esmo2019
[12] breast,cancer
[11] esmo,2019
[10] #esmo19,barcelona
[9] medical,oncology
[8] attending,#esmo19
[8] european,society
[8] society,medical
[7] #esmo2019,#barcelona
[7] #esmo2019,barcelona

Top Word Pairs in Tweet in G10:
[45] cancer,#esmo19
[40] toxicity,profiling
[40] profiling,immunotherapy
[40] immunotherapy,cancer
[40] #esmo19,#day3
[40] #day3,myesmo
[33] #esmo19,bopacommittee
[21] #esmo19,myesmo
[12] lung,cancer
[12] booth,p435

Top Replied-To
Top Replied-To in Entire Graph:
@myesmo
@cancernurseeu
@annals_oncology
@weoncologists
@anzuptrials
@drsanjaypopat
@ruthkilcawley
@drchoueiri
@innatepharma
@fabioschutz78

Top Replied-To in G1:
@myesmo
@weoncologists
@annals_oncology
@drsanjaypopat
@tony_calles
@geoff_oxnard
@apassaromd
@oncoinfo_it
@nicolekuderer
@cancernurseeu

Top Replied-To in G2:
@anzuptrials
@fabioschutz78
@neerajaiims
@montypal
@drchoueiri
@myesmo
@soaresandrey
@prof_iand
@oncoblogg
@ejonasch

Top Replied-To in G3:
@cancernurseeu
@ruthkilcawley
@oncologynursing
@myesmo
@umcure2020
@sharp_lena
@eortc
@vjoncology
@julio_delatorre
@druryal

Top Replied-To in G4:
@myesmo
@charityammf
@chrisheery
@doccatenacci
@petitprez_f
@trioncology
@jasonlukemd
@pateloncology
@neerajaiims
@erikahamilton9

Top Replied-To in G5:
@innatepharma
@jacobplieth
@bertrandbio
@zymeworksinc
@drchoueiri
@northwellhealth
@andybiotech
@shaalanbeg
@danchenmdphd
@byamybrown

Top Replied-To in G6:
@myesmo
@nreguart
@karinwinters
@hagsie
@prof_iand
@vprasadmdmph
@profglongmia
@labsadanandam
@davidpesantez1
@sltc21

Top Replied-To in G7:
@jsoriamd

Top Replied-To in G8:
@myesmo
@hazelroddam1
@bayerpharma
@swallowsgroup
@gsk_careers
@piarellaperalta
@50sac
@ikccorg
@tobiashelmstorf

Top Replied-To in G10:
@pharminpractice
@duncomberob

Top Mentioned
Top Mentioned in Entire Graph:
@myesmo
@oncoalert
@cancernurseeu
@nejm
@weoncologists
@matteolambe
@urotoday
@peters_solange
@drchoueiri
@drenriquegrande

Top Mentioned in G1:
@myesmo
@oncoalert
@matteolambe
@peters_solange
@weoncologists
@nejm
@ramalingammd
@annals_oncology
@gustaveroussy
@drsanjaypopat

Top Mentioned in G2:
@myesmo
@oncoalert
@urotoday
@drenriquegrande
@drchoueiri
@mocbrasil
@uromigos
@pcaparker
@montypal
@fabioschutz78

Top Mentioned in G3:
@myesmo
@cancernurseeu
@oncoalert
@weoncologists
@vjoncology
@ukonsmember
@cmlnet
@cancerlead
@ncri_partners
@knowyournodes

Top Mentioned in G4:
@myesmo
@nejm
@mdandersonnews
@skopetz
@pfizer
@foxtrotstudy
@jenseligmann
@cancerfrontline
@agrothey
@letswinpc

Top Mentioned in G5:
@vantageanalysis
@myesmo
@byamybrown
@cancerresearch
@natrevdrugdisc
@jacobplieth
@oncoalert
@naturemedicine
@gustaveroussy
@uzbrussel

Top Mentioned in G6:
@royalmarsdennhs
@icr_london
@hospitalclinic
@myesmo
@medscapecme
@aggieleemd
@dkarikios
@anupriyaa
@narcyzghinea
@prat_aleix

Top Mentioned in G7:
@scienceatbms
@agonigrammi
@blood_pac

Top Mentioned in G8:
@myesmo
@danielebanfi83
@bayerpharma
@pfizer_france
@novartis
@dkkhanna65
@uclanresearch
@bettinaryll
@scottflenhealth
@swallowsgroup

Top Mentioned in G9:
@servieroncoarg
@redshedmedia
@medexpresspl
@posterwalk

Top Mentioned in G10:
@myesmo
@bopacommittee
@jamaonc
@dharmisha
@geoffsau
@anacasbal
@viforpharmaes
@beabernardez
@belnpadrn3
@sgoncos

Top Tweeters
Top Tweeters in Entire Graph:
@americanair
@oldlady12345
@clarita_mate
@hrblock_21
@heelleclech
@llemj
@inabster
@machi_usagi
@lehimesa
@cronicas_diary

Top Tweeters in G1:
@machi_usagi
@soniaerasmus
@mesonco
@nembotavy_0101
@galarole08
@wouterveldhoen
@abcdiagnosis
@margymayell
@jazzmanahn
@nxtstop1

Top Tweeters in G2:
@cronicas_diary
@lavanguardia
@a3noticias
@lugwaja
@nachodeferrol
@dailymailuk
@acuervomont
@hubbucket
@beautifulmumsie
@lluis1966

Top Tweeters in G3:
@repubblica
@ramiro1504p
@rosenchild
@sdmcardenadenis
@breakingnewsie
@angiebeeb
@parvez1
@chezmik
@laporres
@irpsych

Top Tweeters in G4:
@oldlady12345
@clarita_mate
@hrblock_21
@onahunttoday
@pvalsfr
@npsusa
@baronianconsult
@1chefdiva
@swensonmember
@thebayzdonyae

Top Tweeters in G5:
@americanair
@threadreaderapp
@passarelliallan
@gambiste1
@gofloors
@jhcpw
@stfuimtweetn0_o
@myglobalpac
@yahoofinance
@darylmox

Top Tweeters in G6:
@kimvie
@kellyclelland1
@drginareghetti
@ansisegle
@ayirpelle
@radoslavradosla
@benzinga
@marymaryregan
@cholericcleric
@nicolettamall

Top Tweeters in G7:
@inabster
@lehimesa
@manchuriandevil
@burberryant
@lynxie63
@safimaasai
@willsmirk4food
@moveover4me2
@joylladiebnx
@stevekloscak

Top Tweeters in G8:
@heelleclech
@inachiveg
@altai_armande
@bo_chart
@roxanemlp
@clpeqt
@dormousegirl
@oui2oui3
@julienramauge
@alsheikh_najah

Top Tweeters in G9:
@infoitsalute
@saeedbaygi
@bigdatabatman
@trendsbarcelona
@evalinadexter
@radiodiscapacid
@emurshid
@chris_chocobo
@stejar58
@roseramills

Top Tweeters in G10:
@adnanserpen
@gmacscotland
@jama_current
@hey_alf
@pablosotelog
@armunyoz
@martarodriguezf
@sefh_
@chiarbor
@magil2006


We use necessary cookies to make our site work. We’d like to set additional cookies to understand site usage, make site improvements and to remember your settings. We also use cookies set by other sites to help deliver content from their services.